A Phase 2, Double-blind, Parallel-group Comparative Study 2 of TS-091 in Patients with Narcolepsy
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 17 Dec 2018
At a glance
- Drugs TS 091 (Primary)
- Indications Narcolepsy
- Focus Therapeutic Use
- Sponsors Taisho Pharmaceutical
- 07 Dec 2018 Status changed from recruiting to active, no longer recruiting.
- 05 Sep 2017 Status changed from not yet recruiting to recruiting.
- 01 Sep 2017 New trial record